OpenAlex
PricingAboutJobs
Log inGet started
Work

The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106

HTML

Year: 2010
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-09-0938
Authors: Michael I. Walton, Paul D. Eve, Angela Hayes, Melanie Valenti, Alexis De Haven Brandon, Gary Box, Kathy J. Boxall, G. Wynne Aherne, Suzanne A. Eccles, Florence I. Raynaud, David H. Williams, John C. Reader, Ian Collins, Michelle D. Garrett
Institutions: Institute of Cancer Research, Cancer Research UK
Language: English

Topic: DNA Repair Mechanisms
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: CHK1 inhibitor, DNA damage checkpoint, p53-deficient tumors, etoposide, gemcitabine, SN-38, irinotecan, CDK1 phosphorylation, γH2AX, PARP cleavage, combination chemotherapy, colon cancer
SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Research UK, National Institute for Health and Care Research
Award: G513727605
OpenAlex ID: W2139291133
FWCI: 4.685
Cites: 48
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms